Health Care & Life Sciences » Pharmaceuticals | Hainan Haiyao Co. Ltd.

Hainan Haiyao Co. Ltd. A | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,040
1,371
1,664
1,521
1,801
2,445
Cost of Goods Sold (COGS) incl. D&A
606
811
968
746
981
1,200
Gross Income
435
560
695
775
820
1,245
SG&A Expense
291
312
401
524
658
997
EBIT
138
246
288
284
160
237
Unusual Expense
-
-
6
7
3
21
Non Operating Income/Expense
41
20
45
40
60
121
Interest Expense
80
104
111
121
222
332
Pretax Income
134
222
256
210
136
168
Income Tax
26
36
40
36
25
41
Equity in Affiliates
7
16
18
14
30
25
Consolidated Net Income
102
171
198
159
81
102
Net Income
94
163
195
165
87
120
Net Income After Extraordinaries
94
163
195
165
87
120
Net Income Available to Common
94
163
195
165
87
120
EPS (Basic)
0.10
0.17
0.18
0.14
0.07
0.09
Basic Shares Outstanding
990
990
1,074
1,172
1,333
1,297
EPS (Diluted)
0.09
0.16
0.18
0.14
0.06
0.09
Diluted Shares Outstanding
990
990
1,075
1,172
1,333
1,297
EBITDA
181
293
344
368
265
362
Other Operating Expense
6
2
7
33
2
11
Non-Operating Interest Income
27
29
18
51
140
159
Minority Interest Expense
8
8
2
5
5
17

About Hainan Haiyao Co.

View Profile
Address
No. 192 Nanhai Avenue
Haikou Hainan 570311
China
Employees -
Website http://www.haiyao.com.cn
Updated 07/08/2019
Hainan Haiyao Co., Ltd. engages in the research, development, manufacture and sale of medicines and medical instrument. Its products consist of six categories, including cephalosporin series, stomach and intestine medicines, anti-tumor medicines, cochlear implant series, bulk drugs and intermediate series. The company was founded in 1965 and is headquartered in Haikou, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.